Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemia.

Wenwen WangTilmann BochtlerPatrick WuchterLinda MantaHaiju HeVolker EcksteinAnthony D HoChristoph Lutz

Published in: European journal of haematology (2017)

Our data suggest that hMSC contribute to quiescence and therapy resistance of persistent AML cells.

Keyphrases